NCT02861846View on ClinicalTrials.gov

Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

March 16, 2023

Study Completion Date

March 16, 2023

Conditions

Epilepsy

Interventions

BIOLOGICAL

profile of CSF biomarkers of AD

dosage of biomarker of AD

Trial Locations (4)

69500

Hospices Civils de Lyon, Bron

Unknown

CHU Gabriel- Montpied, Clermont-Ferrand

CHU des Alpes, Grenoble

CHU Hôpital Nord, Saint-Etienne

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER

NCT02861846 - Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy | Biotech Hunter | Biotech Hunter